Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116915714 | 11691571 | 4 | F | 20160912 | 20151102 | 20160915 | PER | US-PFIZER INC-2015364391 | PFIZER | 70.00 | YR | F | Y | 0.00000 | 20160915 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116915714 | 11691571 | 1 | PS | CELEBREX | CELECOXIB | 1 | Oral | 200 MG, 1X/DAY (WITH MEAL) | C140311 | 20998 | 200 | MG | CAPSULE, HARD | QD | |||||
| 116915714 | 11691571 | 2 | SS | CELEBREX | CELECOXIB | 1 | Oral | 200 MG, DAILY (WITH MEAL) | 20998 | 200 | MG | CAPSULE, HARD | |||||||
| 116915714 | 11691571 | 3 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 300 MG, 1X/DAY | 0 | 300 | MG | TABLET | QD | ||||||
| 116915714 | 11691571 | 4 | C | ASPIRIN. | ASPIRIN | 1 | 81 MG, DAILY | 0 | 81 | MG | TABLET | ||||||||
| 116915714 | 11691571 | 5 | C | CALCIUM | CALCIUM | 1 | Oral | 500 MG, UNK | 0 | 500 | MG | TABLET | |||||||
| 116915714 | 11691571 | 6 | C | ESOMEPRAZOLE MAGNESIUM. | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 40 MG, 2X/DAY | 0 | 40 | MG | MODIFIED-RELEASE CAPSULE, HARD | BID | ||||||
| 116915714 | 11691571 | 7 | C | GLUCOSAMINE | GLUCOSAMINE | 1 | Oral | 500 MG, UNK | 0 | 500 | MG | CAPSULE | |||||||
| 116915714 | 11691571 | 8 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Oral | 25 MG, 1X/DAY | 0 | 25 | MG | TABLET | QD | ||||||
| 116915714 | 11691571 | 9 | C | KRILL OIL | DIETARY SUPPLEMENT | 1 | Oral | 300 MG, UNK | 0 | 300 | MG | CAPSULE | |||||||
| 116915714 | 11691571 | 10 | C | LOSARTAN POTASSIUM. | LOSARTAN POTASSIUM | 1 | Oral | 100 MG, 1X/DAY | 0 | 100 | MG | TABLET | QD | ||||||
| 116915714 | 11691571 | 11 | C | LOVASTATIN. | LOVASTATIN | 1 | Oral | 40 MG, 1X/DAY ( 2 TABLETS OF 20 MG AT BEDTIME) | 0 | 40 | MG | TABLET | QD | ||||||
| 116915714 | 11691571 | 12 | C | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | Oral | 100 MG, 2X/DAY | 0 | 100 | MG | TABLET | BID | ||||||
| 116915714 | 11691571 | 13 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 3 TABLETS DAILY FOR 2 DAYS, 2 TABLETS DAILY FOR 2 DAYS AND 1 TABLET DAILY FOR 2DAY | 0 | TABLET | |||||||||
| 116915714 | 11691571 | 14 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | Oral | 1000 IU, UNK | 0 | 1000 | IU | CAPSULE |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 116915714 | 11691571 | 1 | Arthralgia |
| 116915714 | 11691571 | 2 | Osteoarthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 116915714 | 11691571 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 116915714 | 11691571 | Arthralgia | |
| 116915714 | 11691571 | Condition aggravated | |
| 116915714 | 11691571 | Discomfort | |
| 116915714 | 11691571 | Pain in extremity |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 116915714 | 11691571 | 1 | 20150209 | 0 | ||
| 116915714 | 11691571 | 3 | 20151012 | 0 | ||
| 116915714 | 11691571 | 5 | 20150814 | 0 | ||
| 116915714 | 11691571 | 7 | 20150814 | 0 | ||
| 116915714 | 11691571 | 8 | 20150319 | 0 | ||
| 116915714 | 11691571 | 9 | 20150814 | 0 | ||
| 116915714 | 11691571 | 10 | 20150319 | 0 | ||
| 116915714 | 11691571 | 11 | 20111115 | 0 | ||
| 116915714 | 11691571 | 12 | 20111025 | 0 | ||
| 116915714 | 11691571 | 13 | 20160822 | 0 | ||
| 116915714 | 11691571 | 14 | 20150814 | 0 |